Artificial Intelligence-assisted Colonoscopy With or Without Endocuff Vision
Adenoma detection rate (ADR) is considered the single most important quality measure in colonoscopy and a higher ADR can reduce the risk of interval colorectal cancer (CRC). Several kinds of new endoscopes and accessories have been accessed to investigate the abilities of improving the ADR. Artificial intelligence (AI)
| Condition(s) | Adenoma Detection Rate |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Adenoma detection rate (ADR) is considered the single most important quality measure in colonoscopy and a higher ADR can reduce the risk of interval colorectal cancer (CRC). Several kinds of new endoscopes and accessories have been accessed to investigate the abilities of improving the ADR. Artificial intelligence (AI) and Endocuff vision are promising new devices to improve the ADR. However, the effect of combining AI and Endocuff vision on ADR remains unclear. The aim of this prospective randomized study is to compare the ADR of AI plus Endocuff vision, AI alone and standard colonoscopy examination. |
| Who can participate | Inclusion Criteria: Patients over 20 years old are undergoing outpatient sedative colonoscopy in the E-Da Hospital, E-Da cancer Hospital and Chung Shan Medical University Hospital in Taiwan Exclusion Criteria: * A prior history of of inflammatory bowel disease, colorectal cancer, previous bowel resection, Peutz-Jeghers syndrome, familial adenomatous polyposis or other polyposis syndromes * Bleeding tendency * For scheduled endoscopic treatment |
| Ages | 40 Years |
| Sex | All |
| Lead sponsor | E-DA Hospital |
| Locations | Kaohsiung City, Taiwan |
| Start date | 2023-05-02 |
| NCT ID | NCT05863208 |
| Official listing | https://clinicaltrials.gov/study/NCT05863208 |